TABLE 2.
Summary of results from cotesting with Pap and HPV by 10-year age groups
| Total |
Pap + |
HPV+ |
Pap− / HPV− |
Pap+/ HPV− |
Pap−/HPV+ |
Pap+/ HPV+ |
Prevalence ratio (HPV/Pap) (95% CI) |
P valuea | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age group | n | % | n | % | n | % | n | % | n | % | n | % | n | % | ||
| 30-39 | 620 | 27.6% | 38 | 6.1% | 64 | 10.3% | 542 | 87.4% | 14 | 2.3% | 40 | 6.5% | 24 | 3.9% | 1.68 (1.26–2.26) | < .001b |
|
| ||||||||||||||||
| 40-49 | 941 | 41.9% | 57 | 6.1% | 67 | 7.1% | 834 | 88.6% | 40 | 4.3% | 50 | 5.3% | 17 | 1.8% | 1.18 (0.87–1.59) | .292 |
|
| ||||||||||||||||
| 50-60 | 685 | 30.5% | 39 | 5.7% | 31 | 4.5% | 626 | 91.4% | 28 | 4.1% | 20 | 2.9% | 11 | 1.6% | 0.79 (0.54–1.17) | .248 |
|
| ||||||||||||||||
| Total | 2246 | 100% | 134 | 6.0% | 162 | 7.2% | 2002 | 89.1% | 82 | 3.7% | 110 | 4.9% | 52 | 2.32% | 1.21 (1.01–1.45) | .043a,b |
Prevalence ratio (HPV/Pap), ratio of the prevalence of a positive HPV test to the prevalence of a positive cytologic interpretation. Pap + includes atypical squamous cells of undetermined significance, low grade squamous intraepithelial lesion, high grade squamous intraepithelial lesion, atypical glandular cells of undetermined significance, atypical glandular cells, adenocarcinoma; HPV + includes HPV positive.
CI, confidence interval; HPV, human papillomavirus test; Pap, Papanicolaou test.
a
McNemar’s χ2 test;
b
Statistically significantly (P < .05) greater number of HPV positives vs Pap positives.